Sun Pharmaceuticals reported INR78.62B in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Aspen Pharmacare APN:SJ 939.5B 930.9B
Bharat Petroleum BPCL:IN 29.54B 105.98B
Cipla CIPLA:IN 33.51B 2.37B
Dr.Reddys Laboratories DRRD:IN 33.22B 2.56B
Jiangsu Hengrui Me. 600276:CH CH 3.87B 698.29M
Reliance Infra RELI:IN IR 724350M 100690M
Sh Fosun Pharma 600196:CH CH 5.19B 721.16M
Sun Pharmaceuticals SUNP:IN IR 78615.6M 9544.3M
UPL UPLL:IN 61.57B 17.1B